TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · no major macro event
TENX

Tenax Therapeutics Inc

Healthcare · Biotechnology

1.60$ +0.6% vs. previous close Closing price · As of: Nov 13, 2026

Ownership

Ownership Structure

Who owns Tenax Therapeutics Inc (TENX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 83.4% of the shares are freely tradable; institutional investors hold 63.4%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 63.4%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 0.1%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 83.4%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 12.9%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 46Mio.

Largest Shareholders

Institutions

Institutions TENX
Name Stake (%) Shares Change (%) Date
FMR Inc 8.66 3,942,373 +1,122.1 06/30/2026
Vivo Capital, LLC 5.49 2,500,000 +1,100.0 06/30/2026
BlackRock Inc 3.79 1,727,988 +10,078.4 06/30/2026
Perceptive Advisors LLC 3.73 1,700,000 +17.4 06/30/2026
Vanguard Capital Management, LLC 2.52 1,147,121 +335.5 06/30/2026
Millennium Management LLC 1.92 876,230 +64.1 06/30/2026
Ikarian Capital, LLC 1.73 787,600 -22.6 06/30/2026
Candriam Luxembourg S.C.A. 1.65 749,588 +0.0 06/30/2026

Funds

Funds TENX
Name Stake (%) Shares Change (%) Date
iShares Russell 2000 ETF 1.97 898,558 +0.0 10/30/2026
Vanguard MStar Total Stk Mkt Idx Invest 1.87 852,259 +0.0 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings TENX
Person Role Shares Value As of Type
ADAR1 Capital Management, LLC 10% Owner 7,447,000 11,915,200 $ Oct 21, 2026 indirect
Doogan Declan Director 55,274 88,438 $ Sep 16, 2026 direct
Giordano Christopher Thomas CEO 22,174 35,478 $ Sep 15, 2026 direct
Staab Thomas R Ii Chief Financial Officer 15,675 25,080 $ Sep 11, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Oct 21, 2026 ADAR1 Capital Management, LLC 10% Owner Buy 331,979 1.66 550,687
Oct 20, 2026 ADAR1 Capital Management, LLC 10% Owner Buy 254,342 1.60 405,726
Oct 19, 2026 ADAR1 Capital Management, LLC 10% Owner Buy 336,528 1.51 507,013
Sep 16, 2026 Doogan Declan Director Buy 53,000 1.92 101,760
Sep 15, 2026 Giordano Christopher Thomas CEO Buy 4,850 1.82 8,837
Sep 11, 2026 Giordano Christopher Thomas CEO Buy 6,000 1.88 11,250
Sep 11, 2026 Staab Thomas R Ii Chief Financial Officer Buy 5,675 1.94 10,981
Sep 3, 2026 ADAR1 Capital Management, LLC 10% Owner Buy 900,000 1.78 1,604,160
Sep 2, 2026 ADAR1 Capital Management, LLC 10% Owner Buy 187,704 1.80 337,586
Sep 1, 2026 ADAR1 Capital Management, LLC 10% Owner Buy 179,058 1.80 321,570
Aug 31, 2026 ADAR1 Capital Management, LLC 10% Owner Buy 403,571 1.79 722,594
Aug 24, 2026 ADAR1 Capital Management, LLC 10% Owner Buy 107,374 1.75 188,355
Aug 21, 2026 ADAR1 Capital Management, LLC 10% Owner Buy 716,369 1.77 1,266,254
Aug 20, 2026 ADAR1 Capital Management, LLC 10% Owner Buy 202,124 1.78 359,538

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?